XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents ($401 and $333 related to VIEs) $ 2,172 $ 2,829
Marketable securities ($54 and $59 related to VIEs) 99 130
Accounts receivable, net ($76 and $92 related to VIEs) 1,081 921
Contract assets ($71 and $130 related to VIEs) 1,489 1,138
Other current assets ($23 and $32 related to VIEs) 186 157
Total current assets 5,027 5,175
Noncurrent assets    
PP&E, net ($43 and $46 related to VIEs) 484 494
Investments 5,616 2,828
Other assets ($20 and $17 related to VIEs) 661 646
Total noncurrent assets 6,761 3,968
Total assets 11,788 9,143
Current liabilities    
Accounts payable ($227 and $233 related to VIEs) 1,439 1,220
Contract liabilities ($257 and $278 related to VIEs) 683 684
Accrued salaries, wages and benefits ($22 and $18 related to VIEs) 602 640
Other accrued liabilities ($50 and $37 related to VIEs) 378 527
Total current liabilities 3,102 3,071
Long-term debt 1,070 1,104
Deferred taxes 1,160 468
Other noncurrent liabilities 478 508
Commitments and contingencies
Shareholders’ equity    
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 162,423,864 and 169,228,759 shares in 2025 and 2024, respectively 2 2
APIC 887 1,174
AOCI (279) (351)
Retained earnings 5,339 3,124
Total shareholders’ equity 5,949 3,949
NCI 29 43
Total equity 5,978 3,992
Total liabilities and equity $ 11,788 $ 9,143